Share On Social!
The rise of the Latino population makes it urgent to tackle disparities in obesity, diabetes, and cancer.
But did you know fewer than 5% percent of Latinos participate in federal clinical trials?
Researchers thus have less chance to develop new cancer treatments for this population, which suffers a heavy burden of certain cancers, obesity, and mental health issues.
That’s why we’re excited to use #SaludTues on Oct. 16, 2018, to tweet about how to increase Latino participation in clinical trials to prevent health disparities, as Hispanic Heritage Month draws to a close!
- WHAT: Bilingual Tweetchat: “Hispanic Heritage Month: Latinos and Clinical Trials”
- TIME/DATE: 1-2 p.m. ET (Noon-1 p.m. CT), Tuesday, Oct. 16, 2017
- WHERE: On Twitter with hashtag #SaludTues
- HOST: @SaludToday
- CO-HOSTS: The All of Us research program (@AllofUsResearch), Eric Dishman, director of the All of Us research program (@ericdishman), National Cancer Institute (@NCICancerTrials & @NCIespanol)
We’ll open the floor to your comments, tips, and stories as we explore:
- All about clinical trials;
- The importance of clinical trials for Latinos;
- Barriers and enablers to clinical trial participation; and
- Strategies to increase Hispanic/Latino minority enrollment;
Be sure to use the hashtag #SaludTues to follow the conversation on Twitter in English or Spanish, and share stories and resources to boost minority clinical trial participation.
“Most of today’s best cancer treatments are based on what we learned from past clinical trials,” said Dr. Amelie G. Ramirez, leader of the Salud America! and director of the Institute for Health Promotion Research at UT Health San Antonio. “The more Latinos join clinical trials, the faster we can find better cancer treatments and prevention options and increase survival rates.”
Click here to learn about the Salud America! #SaludTues tweetchats, see upcoming and past tweetchats, and see how you can get involved.